News Viridian Eye Disease Drug Surpasses Expectations in Late-stage Trial; Shares Soar by Medscape • 2026/05/05 • 0 Comments Viridian Therapeutics said on Tuesday its experimental thyroid eye disease drug met the main goal of a late-stage trial in chronic patients, sending its shares up nearly... Reuters Health Information